Lancet 394 , 121130 (2019)
Liraglutide (the active ingredient in Saxenda and Victoza) and semaglutide (the active ingredient in Ozempic) are two of the most studied options, and while they work through the same pathway, they differ in dosing, potency, side effects, and the kind of support they offer over time
The beta testing was pretty extensive, but the community was more about feedback and the app, not user glp-1 journeys
Como la tirzepatida tambin acta sobre el receptor de GLP-1, reproduce gran parte de estos efectos, funcionando como un GLP-1 sinttico
Those are worth raising with your provider, both because they affect your weight plan and because some symptoms deserve their own evaluation rather than being brushed off as just menopause